Diabetic neuropathy of the lower extremities: diagnostic route of the patient (clinical case)
Vol. 15 No. 2 (2026), NEW ADVANCED
Vol. 15 No. 2 (2026)

Diabetic neuropathy of the lower extremities: diagnostic route of the patient (clinical case) : УДК: 616.379-008.64 : 616.833-002-003.8

NEW ADVANCED
https://doi.org/10.57105/2415-7252-2026-2-01
Published 2026-04-08
M. S. Nechyporenko
Department of Age-Related Cardiometabolic Diseases, D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
https://orcid.org/0000-0002-5375-4370
V. O. Lutsenko
Department of Age-Related Cardiometabolic Diseases, D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
https://orcid.org/0009-0003-0987-0483
O. E. Ozeryanska
Department of Treatment and Rehabilitation of Patients with Cardiometabolic Diseases, D. F. Chebotarev Institute of Gerontology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
Ya. A. Sayenko
Department of Age-Related Cardiometabolic Diseases, D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
https://orcid.org/0000-0003-1953-1066
PDF article (Українська)

Keywords

diabetes mellitus
diabetic polyneuropathy
electroneuromyography
SUDOSCAN
diabetic retinopathy

Abstract

Diabetic neuropathy (DN) is one of the most common complications of diabetes mellitus (DM) and represents a significant medical and social problem due to its high prevalence, substantial impact on patients’ quality of life, and association with severe complications. Despite significant progress in diagnosis, some patients remain undiagnosed, especially in the early stages when clinical symptoms are not pronounced. Therefore, current guidelines emphasize regular screening using standardized methods of sensory evaluation, vibration threshold testing, and electroneuromyography. We described a clinical case of a patient with typical complications of type 2 diabetes and presented in detail the optimal diagnostic pathway for such patients. The use of a multidisciplinary approach combining endocrinological, neurological, and cardiovascular examinations in accordance with global recommendations can delay the development of irreversible complications.

https://doi.org/10.57105/2415-7252-2026-2-01
PDF article (Українська)

References

1. Kishore, TN Ravi, Satya Srividya Kalluri, and Venugopal Sarveswaran. «A Prospective Study on Independent Risk Factors for Lower Limb Amputation in Diabetic Foot Patients.» European Journal of Cardiovascular Medicine 15 (2025): 405-411. DOI : 10.61336/ejcm/25-10-71

2. Hicks CW, Wang D, Matsushita K, et al. Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults: A Prospective Cohort Study Ann Intern Med. 2021;174(2):167-174. https://doi.org/10.7326/m20-1340

3. Sun, H. et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 183, 109119 (2022). doi: 10.1016/j.diabres.2021.109119

4. Sun J, Wang Y, Zhang X, et al. Prevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta- analysis. Primary Care Diabetes, 2020; 14, 435-444. https://doi. org/10.1016/j.pcd.2019.12.005

5. Yang Y, Zhao B, Wang Y, Lan H, Liu X, Hu Y, Cao P. Diabetic neuropathy: cutting-edge research and future directions. Signal Transduct Target Ther. 2025 Apr 25;10(1):132. doi: 10.1038/ s41392-025-02175-1. PMID: 40274830; PMCID: PMC12022100.

6. Zhou P, Zhou JS, Li JJ, Qin L, Hu WF, Zhang XY, Wang JX, Shi Z. Prevalence and risk factors for painful diabetic peripheral neuropathy: a systematic review and meta-analysis. Front Neu rol. 2025 May 13;16:1564867. doi: 10.3389/fneur.2025.1564867. PMID: 40433609; PMCID: PMC12108811.

7. Pop-Busui, R. et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care 40, 136–154 (2017). https://doi.org/10.2337/dc16-2042

8. Mankovsky B.M. (2021).Diabetychna neiropatiia: vid holovy do kinchykiv paltsiv (Diabetic Neuropathy: From Head to Fingertips).Kyiv: Vira Prodzhekt. ISBN 978-617-95107-1-7.

9. American Diabetes Association Professional Practice Committee for Diabetes*; 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026. Diabetes Care 1 January 2026; 49 (Supplement_1): S261–S276. https://doi. org/10.2337/dc26-S012

10. Mach F, Koskinas KC, Roeters van Lennep JE, Tokgözoğlu L, Badimon L, Baigent C, Benn M, Binder CJ, Catapano AL, De Backer GG, Delgado V, Fabin N, Ference BA, Graham IM, Landmesser U, Laufs U, Mihaylova B, Nordestgaard BG, Richter DJ, Sabatine MS; ESC/EAS Scientific Document Group. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the man- agement of dyslipidaemias. Eur Heart J. 2025 Nov 7;46(42):4359- 4378. doi: 10.1093/eurheartj/ehaf190. PMID: 40878289.

11. Burger PM, Dorresteijn JAN, Koudstaal S, Holtrop J, Kastelein JJP, Jukema JW, Ridker PM, Mosterd A, Visseren FLJ. Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials. Atherosclerosis. 2024 Sep; 396:118540. doi: 10.1016/j.atherosclerosis. 2024.118540. Epub 2024 Jul 11. PMID: 39126771.

12. Tesfaye S, Boulton AJM, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285– 2293. https://doi.org/10.2337/dc10-1303

13. Morten Charles, Sabita S. Soedamah-Muthu, Solomon Tesfaye, John H. Fuller, Joseph C. Arezzo, Nishi Chaturvedi, Daniel R. Witte, EURODIAB Prospective Complications Study Investigators; Low Peripheral Nerve Conduction Velocities and Amplitudes Are Strongly Related to Diabetic Microvascular Complications in Type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care. 1 December 2010; 33 (12): 2648–2653. https://doi. org/10.2337/dc10-0456

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.